In the News
-
Shire Announces European Approval of Manufacturing Facility for VPRIV
24 February 2012
European Medicines Agency Approval Adds Significant Capacity for the Manufacture of Shire’s Enzyme Replacement Therapies Shi...
Read more....
-
Genzyme Announces FDA Approval of Framingham Manufacturing Plant
08 February 2012
Genzyme, a Sanofi company, announced today that the US Food and Drug Administration (FDA) has approved its manufacturing plant in Framingham, Mass....
Read more....
-
Protalix Announces New Clinical Data on Taliglucerase Alfa to be Presented at the WORLD Lysosomal Disease Network Symposium
08 February 2012
Protalix BioTherapeutics, announced today that new clinical data on taliglucerase alfa will be presented at the 8th Annual Meeting of the Lysosomal...
Read more....